On November 3, 2020, Wynnefield Capital, Inc. announced that it intends to seek board representation through the nomination of a slate of directors to replace the current incumbent board at MusclePharm Corporation’s next annual meeting of stockholders which the Wynnefield note has not been held since December 2018.